Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort
Crossref DOI link: https://doi.org/10.1186/s13075-016-0969-2
Published Online: 2016-03-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Ciurea, Adrian
Exer, Pascale
Weber, Ulrich
Tamborrini, Giorgio
Steininger, Beate
Kissling, Rudolf O.
Bernhard, Jürg
Scherer, Almut
Funding for this research was provided by:
AbbVie
Stiftung für Rheumaforschung
